Osteoarthritis

Carol T., 61, wants her fifth quarterly corticosteroid injection for knee osteoarthritis, and the trial everyone cites against repeat injections never actually measured the relief she says she gets. The disagreement is whether a null result on cartilage loss should override ten weeks of real, reported pain relief the trial wasn't designed to capture.

Frank O., 68, wants hyaluronic acid for his knee osteoarthritis after NSAIDs and a corticosteroid injection have both fallen short — and his kidney disease closes off some of what's left. The disagreement is whether a guideline written against this exact therapy still applies once his other options have run out.

Renata S., 66, a school crossing guard who's never really retired from the job, needs an NSAID for her osteoarthritis with both a prior heart attack and a prior GI bleed in her history. The disagreement is that the trial everyone cites to avoid COX-2 inhibitors actually tested it at a dose lower than what NSAIDs are typically used at — a detail that changes what the numbers really say.

T.O., 74, spends his weekend mornings in his garage workshop despite knee and early hip osteoarthritis, complicated by the blood thinner he's on for his heart. The disagreement is how far topical therapy can reasonably carry him before his hip pain outgrows what a topical drug can do.

Denise M., 58, has knee osteoarthritis with pain that spreads well beyond what her imaging can explain. The disagreement is whether duloxetine is treating a real central pain component or just masking something that still needs a closer look — and how long to wait before deciding which one it is.

Walter G., 72, has severe hip osteoarthritis and advanced kidney disease, with his surgery delayed for cardiac clearance he doesn't yet have. The disagreement is how to bridge his pain safely, once the standard tramadol dosing interval turns out to be the wrong one for a kidney like his.

Miguel R., 54, still plays competitive tennis three times a week despite knee osteoarthritis, and wants platelet-rich plasma even though the most rigorous trial ever run on it found no benefit over saline. The disagreement is whether his own informed choice still has a place once the evidence — and the guideline built from it — is stated plainly.

Helen K., 63, has stuck with over-the-counter glucosamine and chondroitin for her knee osteoarthritis and says it genuinely helps. The disagreement is whether she happens to be exactly the one subgroup a major trial found a real effect in, or whether that finding is thinner than it sounds.

Arthur P., 70, has tried NSAIDs, an injection, and physical therapy for severe knee osteoarthritis complicated by a high BMI. The disagreement is whether staying the conservative course still genuinely serves him, or whether that path has quietly become the easier answer rather than the better one.